osteoperosis

Pharma

Entera moves oral rival to Lilly's Forteo toward pivotal trial

Entera Bio has posted midphase data on its oral challenger to Eli Lilly’s injectable osteoporosis drug Forteo, setting it up to begin a phase 3 trial.

Nick Paul Taylor Oct 11, 2021 7:30am

Pfizer launches multiple recalls of menopause drug Duavee

Jun 9, 2020 9:25am

Public Citizen requests FDA black box for Amgen's Prolia

Apr 18, 2019 11:50am

Amgen prices bone drug Evenity on par with rival Tymlos

Apr 16, 2019 12:18pm

Amgen bone drug Evenity wins FDA nod, but with strings attached

Apr 10, 2019 10:38am

Amgen's Evenity 'back in the game' after FDA panel vote

Jan 16, 2019 5:50pm